A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis
about
A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis
description
clinical trial
@en
klinisch onderzoek
@nl
name
A Study of Ixekizumab (LY24398 ...... ate-to-Severe Plaque Psoriasis
@en
type
label
A Study of Ixekizumab (LY24398 ...... ate-to-Severe Plaque Psoriasis
@en
prefLabel
A Study of Ixekizumab (LY24398 ...... ate-to-Severe Plaque Psoriasis
@en
P6153
P1050
P131
P1476
A 24-Week Multicenter, Randomi ...... ate-to-Severe Plaque Psoriasis
@en
P1813
IXORA-R
@en
P3098
NCT03573323
P4844
P580
2018-11-09T00:00:00Z
P582
2019-07-02T00:00:00Z